1. Triple Therapy in Cadaveric Renal Transplantation: Role of Induction Cyclosporine and Targeted Levels to Avoid Rejection
- Author
-
Raja B. Khauli, Jeffrey S. Stoff, John Wilson, Stephen P. Baker, Shauneen A. Valliere, and T Lovewell
- Subjects
Kidney ,medicine.medical_specialty ,business.industry ,Urology ,Azathioprine ,medicine.disease ,Surgery ,Nephrotoxicity ,Transplantation ,medicine.anatomical_structure ,Nifedipine ,Prednisone ,Medicine ,business ,Kidney transplantation ,Whole blood ,medicine.drug - Abstract
The updated data on 61 consecutive cadaveric transplants performed at our institution from 1987 to 1990 (followup 31 to 82 months, median 54 months) were analyzed with emphasis on cyclosporine monitoring and long-term results. All patients received triple therapy with cyclosporine induction, azathioprine and prednisone regardless of graft function, and they were preferentially placed on the calcium blocker nifedipine. We monitored 12-hour cyclosporine trough levels in whole blood using high performance liquid chromatography and the dose was adjusted to maintain levels at 150 ng./ml. or greater for the first 3 months. In 17 of 61 patients (28 percent) 22 rejection episodes occurred and 20 nephrotoxicity episodes occurred in 17 of 61 patients (28 percent). There was no significant difference in the mean cyclosporine levels among 32 rejection, nonrejection, nephrotoxic and nonnephrotoxic cases at any interval. Rejection occurred by 1 month in 13 (76 percent) and by 3 months in 15 (88 percent) of 17 p...
- Published
- 1995
- Full Text
- View/download PDF